| 4.89 0.08 (1.66%) | 12-05 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.24 | 1-year : | 6.91 |
| Resists | First : | 5.34 | Second : | 5.92 |
| Pivot price | 4.71  |
|||
| Supports | First : | 4.4 | Second : | 3.66 |
| MAs | MA(5) : | 4.81 |
MA(20) : | 4.89 |
| MA(100) : | 5.81 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 34 |
D(3) : | 26.9 |
| RSI | RSI(14): 48.3 |
|||
| 52-week | High : | 11.86 | Low : | 4.34 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NYXH ] has closed below upper band by 20.9%. Bollinger Bands are 59.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4.9 - 4.92 | 4.92 - 4.95 |
| Low: | 4.69 - 4.71 | 4.71 - 4.73 |
| Close: | 4.85 - 4.88 | 4.88 - 4.92 |
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Fri, 05 Dec 2025
Nyxoah Announces Shareholding Changes as Robert Taub Surpasses 10% Threshold - TipRanks
Tue, 02 Dec 2025
Publication relating to transparency notifications - GlobeNewswire
Mon, 01 Dec 2025
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System - WV News
Mon, 01 Dec 2025
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System - Yahoo Finance
Thu, 27 Nov 2025
Nyxoah (NASDAQ: NYXH) schedules webcast fireside chat at Piper Sandler healthcare conference - Stock Titan
Wed, 26 Nov 2025
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy - MSN
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 43 (M) |
| Held by Insiders | 1.862e+007 (%) |
| Held by Institutions | 36.2 (%) |
| Shares Short | 261 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.215e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 235.7 % |
| Return on Equity (ttm) | -44 % |
| Qtrly Rev. Growth | 5.64e+006 % |
| Gross Profit (p.s.) | 85.84 |
| Sales Per Share | -165.5 |
| EBITDA (p.s.) | 5.58462e+006 |
| Qtrly Earnings Growth | -2.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -68 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.03 |
| Price to Cash Flow | 2.33 |
| Dividend | 0 |
| Forward Dividend | 238930 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|